Japan’s Astellas Pharma opens its Scientific & Technical Regional Office in Riyadh

By Shilpa Annie Joseph, Official Reporter
  • Follow author on
Officials during the inauguration of Astellas Scientific and Technical Office in Saudi Arabia.

Japanese multinational pharmaceutical company Astellas Pharma has opened its new Scientific and Technical Office in Riyadh, Saudi Arabia.

The office opening is part of the Astellas’ long-term commitment to the Kingdom and stems from the company’s strong belief in leveraging technology to better serve local patients and communities.

Furthermore, it intends to support the local healthcare infrastructure with innovative medicines and treatments.

Leon Moore
Leon Moore
President – International Markets Commercial
Astellas Pharma

“Our Scientific and Technical Office in Riyadh is a natural extension of the work we are already doing globally and aligned with the Saudi government’s efforts to provide world-class and comprehensive healthcare to patients. We foresee many opportunities to work with local authorities and healthcare providers, leveraging our assets and expertise, to bring innovative medicines and treatments to Saudi patients. We’re pleased to be a part of the Vision 2030 journey in building a vibrant biopharmaceutical ecosystem in Saudi Arabia, especially at a time when the pandemic has underscored the importance of timely accessibility to medicines and treatments. I am excited by the opportunities to collaborate with local authorities as well as domestic and international pharmaceutical players and harness our collective synergies for the people of Saudi Arabia.”

The company said that the new Astellas Scientific and Technical Office will facilitate closer partnerships with key stakeholders, industry partners, healthcare providers, and local authorities.

His Excellency Iwai Fumio, Ambassador Extraordinary and Plenipotentiary of Japan to the Kingdom of Saudi Arabia noted that, “I welcome the inauguration of Astellas’s Scientific and Technical Regional office in Riyadh today and it comes at an opportune time to leverage the on-going strategic partnership between Saudi Arabia and Japan and in support of Vision 2030.”

“I believe the Astellas presence in Saudi Arabia will not only elevate the quality of healthcare but also go towards realizing the health and talent empowerment in this country. I hope the success of the Astellas office will motivate more Japanese companies to extend their business footprint in Saudi Arabia,” the Ambassador added.

Related: Abu Dhabi’s Mubadala & EQT Private Equity to acquire Swedish firm Envirotainer